Long-term humoral response following Delta and Omicron BA.1 co-infection.

Carla Saade Bruno Pozzetto Melyssa Yaugel Novoa Guy Oriol Laurence Josset Bruno Lina Stephane Paul Antonin Bal Sophie Touillet-Assant

Published in: NPJ vaccines (2023)

This study reports the 6-month humoral immune response in vaccinated patients concomitantly infected with Delta and Omicron BA.1 variants of SARS-CoV-2. Interestingly, the simultaneous exposure to the Delta and BA.1 S proteins does not confer an additional immune advantage compared to exposure to the BA.1 S protein alone.

Keyphrases

immune response
sars cov
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
dendritic cells
prognostic factors
gene expression
adverse drug
coronavirus disease
inflammatory response
genome wide
copy number
binding protein
small molecule
protein protein